Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex

doi:10.1084/jem.173.4.1007

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Vitiello, A.
	Articles by Chesnut, R. W.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Vitiello, A.
	Articles by Chesnut, R. W.


Social Bookmarking

	What's this?

ARTICLES

Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex

A Vitiello, D Marchesini, J Furze, LA Sherman and RW Chesnut
Department of Cellular Immunology, Cytel Corporation, La Jolla, California 92037.

Transgenic murine lines have been constructed that express a chimeric class I molecule composed of the alpha 1 and alpha 2 domains of HLA- A2.1 and the alpha 3, transmembrane, and cytoplasmic domains of H-2Kb. Upon immunization with influenza virus, transgenic mice developed a strong A2.1Kb-restricted cytotoxic T lymphocyte (CTL) response specific for the same matrix protein epitope that serves as the dominant A2.1- restricted determinant in the equivalent human response. Fine specificity analysis of CTL clones using truncated peptides revealed strong similarity between the response repertoire of transgenic mice and that previously reported using influenza-specific A2.1-restricted CTL clones from humans. This suggests that even when considering T cell responses by different species, the alpha 1 and alpha 2 domains of the restriction element play a dominant role in determining the CTL specific repertoire. Thus, substituting the alpha 3 domain of A2.1 with a murine counterpart has permitted development of a transgenic strain that should serve as an excellent model system in studies of HLA- restricted responses.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Dominguez, A. L., Lustgarten, J. (2008). Implications of Aging and Self-Tolerance on the Generation of Immune and Antitumor Immune Responses. Cancer Res. 68: 5423-5431 [Abstract] [Full Text]
Hahnel, P. S., Thaler, S., Antunes, E., Huber, C., Theobald, M., Schuler, M. (2008). Targeting AKT Signaling Sensitizes Cancer to Cellular Immunotherapy. Cancer Res. 68: 3899-3906 [Abstract] [Full Text]
Takahashi, H., Ishizaki, H., Tahara, H., Tamaki, Y., Yanagi, Y. (2008). Suppression of Choroidal Neovascularization by Vaccination with Epitope Peptide Derived from Human VEGF Receptor 2 in an Animal Model. IOVS 49: 2143-2147 [Abstract] [Full Text]
Marques, C. A., Hahnel, P. S., Wolfel, C., Thaler, S., Huber, C., Theobald, M., Schuler, M. (2008). An immune escape screen reveals Cdc42 as regulator of cancer susceptibility to lymphocyte-mediated tumor suppression. Blood 111: 1413-1419 [Abstract] [Full Text]
Depla, E., Van der Aa, A., Livingston, B. D., Crimi, C., Allosery, K., De Brabandere, V., Krakover, J., Murthy, S., Huang, M., Power, S., Babe, L., Dahlberg, C., McKinney, D., Sette, A., Southwood, S., Philip, R., Newman, M. J., Meheus, L. (2008). Rational Design of a Multiepitope Vaccine Encoding T-Lymphocyte Epitopes for Treatment of Chronic Hepatitis B Virus Infections. J. Virol. 82: 435-450 [Abstract] [Full Text]
Santomasso, B. D., Roberts, W. K., Thomas, A., Williams, T., Blachere, N. E., Dudley, M. E., Houghton, A. N., Posner, J. B., Darnell, R. B. (2007). A T cell receptor associated with naturally occurring human tumor immunity. Proc. Natl. Acad. Sci. USA 104: 19073-19078 [Abstract] [Full Text]
Assarsson, E., Sidney, J., Oseroff, C., Pasquetto, V., Bui, H.-H., Frahm, N., Brander, C., Peters, B., Grey, H., Sette, A. (2007). A Quantitative Analysis of the Variables Affecting the Repertoire of T Cell Specificities Recognized after Vaccinia Virus Infection. J. Immunol. 178: 7890-7901 [Abstract] [Full Text]
Geluk, A., Lin, M. Y., van Meijgaarden, K. E., Leyten, E. M. S., Franken, K. L. M. C., Ottenhoff, T. H. M., Klein, M. R. (2007). T-Cell Recognition of the HspX Protein of Mycobacterium tuberculosis Correlates with Latent M. tuberculosis Infection but Not with M. bovis BCG Vaccination. Infect. Immun. 75: 2914-2921 [Abstract] [Full Text]
Saha, A., Chatterjee, S. K., Foon, K. A., Celis, E., Bhattacharya-Chatterjee, M. (2007). Therapy of Established Tumors in a Novel Murine Model Transgenic for Human Carcinoembryonic Antigen and HLA-A2 with a Combination of Anti-idiotype Vaccine and CTL Peptides of Carcinoembryonic Antigen. Cancer Res. 67: 2881-2892 [Abstract] [Full Text]
Botten, J., Whitton, J. L., Barrowman, P., Sidney, J., Whitmire, J. K., Alexander, J., Ting, J. P. C., Bui, H.-H., Sette, A., Buchmeier, M. J. (2007). HLA-A2-Restricted Protection against Lethal Lymphocytic Choriomeningitis. J. Virol. 81: 2307-2317 [Abstract] [Full Text]
Robek, M. D., Garcia, M. L., Boyd, B. S., Chisari, F. V. (2007). Role of Immunoproteasome Catalytic Subunits in the Immune Response to Hepatitis B Virus. J. Virol. 81: 483-491 [Abstract] [Full Text]
Botten, J., Alexander, J., Pasquetto, V., Sidney, J., Barrowman, P., Ting, J., Peters, B., Southwood, S., Stewart, B., Rodriguez-Carreno, M. P., Mothe, B., Whitton, J. L., Sette, A., Buchmeier, M. J. (2006). Identification of Protective Lassa Virus Epitopes That Are Restricted by HLA-A2.. J. Virol. 80: 8351-8361 [Abstract] [Full Text]
Zhou, M., Xu, D., Li, X., Li, H., Shan, M., Tang, J., Wang, M., Wang, F.-S., Zhu, X., Tao, H., He, W., Tien, P., Gao, G. F. (2006). Screening and Identification of Severe Acute Respiratory Syndrome-Associated Coronavirus-Specific CTL Epitopes. J. Immunol. 177: 2138-2145 [Abstract] [Full Text]
Colombetti, S., Fagerberg, T., Baumgartner, P., Chapatte, L., Speiser, D. E., Rufer, N., Michielin, O., Levy, F. (2006). Impact of Orthologous Melan-A Peptide Immunizations on the Anti-Self Melan-A/HLA-A2 T Cell Cross-Reactivity.. J. Immunol. 176: 6560-6567 [Abstract] [Full Text]
Chapatte, L., Ayyoub, M., Morel, S., Peitrequin, A.-L., Levy, N., Servis, C., Van den Eynde, B. J., Valmori, D., Levy, F. (2006). Processing of Tumor-Associated Antigen by the Proteasomes of Dendritic Cells Controls In vivo T-Cell Responses.. Cancer Res. 66: 5461-5468 [Abstract] [Full Text]
Woo, W.-P., Doan, T., Herd, K. A., Netter, H.-J., Tindle, R. W. (2006). Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes.. J. Virol. 80: 3975-3984 [Abstract] [Full Text]
Herd, K. A., Mahalingam, S., Mackay, I. M., Nissen, M., Sloots, T. P., Tindle, R. W. (2006). Cytotoxic T-Lymphocyte Epitope Vaccination Protects against Human Metapneumovirus Infection and Disease in Mice. J. Virol. 80: 2034-2044 [Abstract] [Full Text]
Peng, L., Ko, E., Luo, W., Wang, X., Shrikant, P. A., Ferrone, S. (2006). CD4-Dependent Potentiation of a High Molecular Weight-Melanoma-Associated Antigen-Specific CTL Response Elicited in HLA-A2/Kb Transgenic Mice. J. Immunol. 176: 2307-2315 [Abstract] [Full Text]
Sewell, R., Backstrom, M., Dalziel, M., Gschmeissner, S., Karlsson, H., Noll, T., Gatgens, J., Clausen, H., Hansson, G. C., Burchell, J., Taylor-Papadimitriou, J. (2006). The ST6GalNAc-I Sialyltransferase Localizes throughout the Golgi and Is Responsible for the Synthesis of the Tumor-associated Sialyl-Tn O-Glycan in Human Breast Cancer. J. Biol. Chem. 281: 3586-3594 [Abstract] [Full Text]
Lustgarten, J., Dominguez, A. L., Pinilla, C. (2006). Identification of Cross-Reactive Peptides Using Combinatorial Libraries Circumvents Tolerance against Her-2/neu-Immunodominant Epitope. J. Immunol. 176: 1796-1805 [Abstract] [Full Text]
Chapatte, L., Colombetti, S., Cerottini, J.-C., Levy, F. (2006). Efficient Induction of Tumor Antigen-Specific CD8+ Memory T Cells by Recombinant Lentivectors. Cancer Res. 66: 1155-1160 [Abstract] [Full Text]
Pasquetto, V., Bui, H.-H., Giannino, R., Mirza, F., Sidney, J., Oseroff, C., Tscharke, D. C., Irvine, K., Bennink, J. R., Peters, B., Southwood, S., Cerundolo, V., Grey, H., Yewdell, J. W., Sette, A. (2005). HLA-A*0201, HLA-A*1101, and HLA-B*0702 Transgenic Mice Recognize Numerous Poxvirus Determinants from a Wide Variety of Viral Gene Products. J. Immunol. 175: 5504-5515 [Abstract] [Full Text]
Miyahara, Y., Naota, H., Wang, L., Hiasa, A., Goto, M., Watanabe, M., Kitano, S., Okumura, S., Takemitsu, T., Yuta, A., Majima, Y., Lemonnier, F. A., Boon, T., Shiku, H. (2005). Determination of Cellularly Processed HLA-A2402-Restricted Novel CTL Epitopes Derived from Two Cancer Germ Line Genes, MAGE-A4 and SAGE. Clin. Cancer Res. 11: 5581-5589 [Abstract] [Full Text]
Chapatte, L., Servis, C., Valmori, D., Burlet-Schiltz, O., Dayer, J., Monsarrat, B., Romero, P., Levy, F. (2004). Final Antigenic Melan-A Peptides Produced Directly by the Proteasomes Are Preferentially Selected for Presentation by HLA-A*0201 in Melanoma Cells. J. Immunol. 173: 6033-6040 [Abstract] [Full Text]
Singh, R. A. K., Barry, M. A. (2004). Repertoire and Immunofocusing of CD8 T Cell Responses Generated by HIV-1 gag-pol and Expression Library Immunization Vaccines. J. Immunol. 173: 4387-4393 [Abstract] [Full Text]
Pajot, A., Pancre, V., Fazilleau, N., Michel, M.-L., Angyalosi, G., Ojcius, D. M., Auriault, C., Lemonnier, F. A., Lone, Y.-C. (2004). Comparison of HLA-DR1-restricted T cell response induced in HLA-DR1 transgenic mice deficient for murine MHC class II and HLA-DR1 transgenic mice expressing endogenous murine MHC class II molecules. Int Immunol 16: 1275-1282 [Abstract] [Full Text]
Liao, Y.-P., Wang, C.-C., Butterfield, L. H., Economou, J. S., Ribas, A., Meng, W. S., Iwamoto, K. S., McBride, W. H. (2004). Ionizing Radiation Affects Human MART-1 Melanoma Antigen Processing and Presentation by Dendritic Cells. J. Immunol. 173: 2462-2469 [Abstract] [Full Text]
Haining, W. N., Anderson, D. G., Little, S. R., von Berwelt-Baildon, M. S., Cardoso, A. A., Alves, P., Kosmatopoulos, K., Nadler, L. M., Langer, R., Kohane, D. S. (2004). pH-Triggered Microparticles for Peptide Vaccination. J. Immunol. 173: 2578-2585 [Abstract] [Full Text]
McKinney, D. M., Skvoretz, R., Livingston, B. D., Wilson, C. C., Anders, M., Chesnut, R. W., Sette, A., Essex, M., Novitsky, V., Newman, M. J. (2004). Recognition of Variant HIV-1 Epitopes from Diverse Viral Subtypes by Vaccine-Induced CTL. J. Immunol. 173: 1941-1950 [Abstract] [Full Text]
Nascimbeni, M., Shin, E.-C., Chiriboga, L., Kleiner, D. E., Rehermann, B. (2004). Peripheral CD4+CD8+ T cells are differentiated effector memory cells with antiviral functions. Blood 104: 478-486 [Abstract] [Full Text]
Snyder, J. T., Belyakov, I. M., Dzutsev, A., Lemonnier, F., Berzofsky, J. A. (2004). Protection against Lethal Vaccinia Virus Challenge in HLA-A2 Transgenic Mice by Immunization with a Single CD8+ T-Cell Peptide Epitope of Vaccinia and Variola Viruses. J. Virol. 78: 7052-7060 [Abstract] [Full Text]
Wang, B., Chen, H., Jiang, X., Zhang, M., Wan, T., Li, N., Zhou, X., Wu, Y., Yang, F., Yu, Y., Wang, X., Yang, R., Cao, X. (2004). Identification of an HLA-A*0201-restricted CD8+ T-cell epitope SSp-1 of SARS-CoV spike protein. Blood 104: 200-206 [Abstract] [Full Text]
Vertuani, S., Sette, A., Sidney, J., Southwood, S., Fikes, J., Keogh, E., Lindencrona, J. A., Ishioka, G., Levitskaya, J., Kiessling, R. (2004). Improved Immunogenicity of an Immunodominant Epitope of the Her-2/neu Protooncogene by Alterations of MHC Contact Residues. J. Immunol. 172: 3501-3508 [Abstract] [Full Text]
Wooldridge, L., Hutchinson, S. L., Choi, E. M., Lissina, A., Jones, E., Mirza, F., Dunbar, P. R., Price, D. A., Cerundolo, V., Sewell, A. K. (2003). Anti-CD8 Antibodies Can Inhibit or Enhance Peptide-MHC Class I (pMHCI) Multimer Binding: This Is Paralleled by Their Effects on CTL Activation and Occurs in the Absence of an Interaction between pMHCI and CD8 on the Cell Surface. J. Immunol. 171: 6650-6660 [Abstract] [Full Text]
Choi, E. M.-L., Chen, J.-L., Wooldridge, L., Salio, M., Lissina, A., Lissin, N., Hermans, I. F., Silk, J. D., Mirza, F., Palmowski, M. J., Dunbar, P. R., Jakobsen, B. K., Sewell, A. K., Cerundolo, V. (2003). High Avidity Antigen-Specific CTL Identified by CD8-Independent Tetramer Staining. J. Immunol. 171: 5116-5123 [Abstract] [Full Text]
Wilson, C. C., McKinney, D., Anders, M., MaWhinney, S., Forster, J., Crimi, C., Southwood, S., Sette, A., Chesnut, R., Newman, M. J., Livingston, B. D. (2003). Development of a DNA Vaccine Designed to Induce Cytotoxic T Lymphocyte Responses to Multiple Conserved Epitopes in HIV-1. J. Immunol. 171: 5611-5623 [Abstract] [Full Text]
Maecker, B., Sherr, D. H., Vonderheide, R. H., von Bergwelt-Baildon, M. S., Hirano, N., Anderson, K. S., Xia, Z., Butler, M. O., Wucherpfennig, K. W., O'Hara, C., Cole, G., Kwak, S. S., Ramstedt, U., Tomlinson, A. J., Chicz, R. M., Nadler, L. M., Schultze, J. L. (2003). The shared tumor-associated antigen cytochrome P450 1B1 is recognized by specific cytotoxic T cells. Blood 102: 3287-3294 [Abstract] [Full Text]
Okazaki, T., Pendleton, C. D., Lemonnier, F., Berzofsky, J. A. (2003). Epitope-Enhanced Conserved HIV-1 Peptide Protects HLA-A2-Transgenic Mice Against Virus Expressing HIV-1 Antigen. J. Immunol. 171: 2548-2555 [Abstract] [Full Text]
Rohrlich, P.-S., Cardinaud, S., Firat, H., Lamari, M., Briand, P., Escriou, N., Lemonnier, F. A. (2003). HLA-B*0702 transgenic, H-2KbDb double-knockout mice: phenotypical and functional characterization in response to influenza virus. Int Immunol 15: 765-772 [Abstract] [Full Text]
Gallez-Hawkins, G., Villacres, M. C., Li, X., Sanborn, M. C., Lomeli, N. A., Zaia, J. A. (2003). Use of Transgenic HLA A*0201/Kb and HHD II Mice To Evaluate Frequency of Cytomegalovirus IE1-Derived Peptide Usage in Eliciting Human CD8 Cytokine Response. J. Virol. 77: 4457-4462 [Abstract] [Full Text]
Wiethe, C., Dittmar, K., Doan, T., Lindenmaier, W., Tindle, R. (2003). Provision of 4-1BB Ligand Enhances Effector and Memory CTL Responses Generated by Immunization with Dendritic Cells Expressing a Human Tumor-Associated Antigen. J. Immunol. 170: 2912-2922 [Abstract] [Full Text]
Charo, J., Sundback, M., Wasserman, K., Ciupitu, A.-M. T., Mirzai, B., van der Zee, R., Kiessling, R. (2002). Marked Enhancement of the Antigen-Specific Immune Response by Combining Plasmid DNA-Based Immunization with a Schiff Base-Forming Drug. Infect. Immun. 70: 6652-6657 [Abstract] [Full Text]
Cheuk, E., D'Souza, C., Hu, N., Liu, Y., Lang, H., Chamberlain, J. W. (2002). Human MHC Class I Transgenic Mice Deficient for H2 Class I Expression Facilitate Identification and Characterization of New HLA Class I-Restricted Viral T Cell Epitopes. J. Immunol. 169: 5571-5580 [Abstract] [Full Text]
Eiben, G. L., Velders, M. P., Schreiber, H., Cassetti, M. C., Pullen, J. K., Smith, L. R., Kast, W. M. (2002). Establishment of an HLA-A*0201 Human Papillomavirus Type 16 Tumor Model to Determine the Efficacy of Vaccination Strategies in HLA-A*0201 Transgenic Mice. Cancer Res. 62: 5792-5799 [Abstract] [Full Text]
Wedemeyer, H., He, X.-S., Nascimbeni, M., Davis, A. R., Greenberg, H. B., Hoofnagle, J. H., Liang, T. J., Alter, H., Rehermann, B. (2002). Impaired Effector Function of Hepatitis C Virus-Specific CD8+ T Cells in Chronic Hepatitis C Virus Infection. J. Immunol. 169: 3447-3458 [Abstract] [Full Text]
Firat, H., Cochet, M., Rohrlich, P.-S., Garcia-Pons, F., Darche, S., Danos, O., Lemonnier, F. A., Langlade-Demoyen, P. (2002). Comparative analysis of the CD8+ T cell repertoires of H-2 class I wild-type/HLA-A2.1 and H-2 class I knockout/HLA-A2.1 transgenic mice. Int Immunol 14: 925-934 [Abstract] [Full Text]
Peter, K., Brunda, M. J., Corradin, G. (2002). IL-12 Administration Leads to a Transient Depletion of T Cells, B Cells, and APCs and Concomitant Abrogation of the HLA-A2.1-Restricted CTL Response in Transgenic Mice. J. Immunol. 169: 63-67 [Abstract] [Full Text]
Huarte, E., Sarobe, P., Lu, J., Casares, N., Lasarte, J. J., Dotor, J., Ruiz, M., Prieto, J., Celis, E., Borras-Cuesta, F. (2002). Enhancing Immunogenicity of a CTL Epitope from Carcinoembryonic Antigen by Selective Amino Acid Replacements. Clin. Cancer Res. 8: 2336-2344 [Abstract] [Full Text]
Alexander, J., Oseroff, C., Dahlberg, C., Qin, M., Ishioka, G., Beebe, M., Fikes, J., Newman, M., Chesnut, R. W., Morton, P. A., Fok, K., Appella, E., Sette, A. (2002). A Decaepitope Polypeptide Primes for Multiple CD8+ IFN-{gamma} and Th Lymphocyte Responses: Evaluation of Multiepitope Polypeptides as a Mode for Vaccine Delivery. J. Immunol. 168: 6189-6198 [Abstract] [Full Text]
Palmowski, M. J., Choi, E. M.-L., Hermans, I. F., Gilbert, S. C., Chen, J.-L., Gileadi, U., Salio, M., Van Pel, A., Man, S., Bonin, E., Liljestrom, P., Dunbar, P. R., Cerundolo, V. (2002). Competition Between CTL Narrows the Immune Response Induced by Prime-Boost Vaccination Protocols. J. Immunol. 168: 4391-4398 [Abstract] [Full Text]
Kiszka, I., Kmieciak, D., Gzyl, J., Naito, T., Bolesta, E., Sieron, A., Singh, S. P., Srinivasan, A., Trinchieri, G., Kaneko, Y., Kozbor, D. (2002). Effect of the V3 Loop Deletion of Envelope Glycoprotein on Cellular Responses and Protection against Challenge with Recombinant Vaccinia Virus Expressing gp160 of Primary Human Immunodeficiency Virus Type 1 Isolates. J. Virol. 76: 4222-4232 [Abstract] [Full Text]
Terasawa, H., Tsang, K.-Y., Gulley, J., Arlen, P., Schlom, J. (2002). Identification and Characterization of a Human Agonist Cytotoxic T-Lymphocyte Epitope of Human Prostate-specific Antigen. Clin. Cancer Res. 8: 41-53 [Abstract] [Full Text]
Singh, R. A. K., Wu, L., Barry, M. A. (2002). Generation of Genome-Wide CD8 T Cell Responses in HLA-A*0201 Transgenic Mice by an HIV-1 Ubiquitin Expression Library Immunization Vaccine. J. Immunol. 168: 379-391 [Abstract] [Full Text]
Wedemeyer, H., Mizukoshi, E., Davis, A. R., Bennink, J. R., Rehermann, B. (2001). Cross-Reactivity between Hepatitis C Virus and Influenza A Virus Determinant-Specific Cytotoxic T Cells. J. Virol. 75: 11392-11400 [Abstract] [Full Text]
Touloukian, C. E., Leitner, W. W., Robbins, P. F., Rosenberg, S. A., Restifo, N. P. (2001). Mining the Melanosome for Tumor Vaccine Targets: P.polypeptide Is a Novel Tumor-associated Antigen. Cancer Res. 61: 8100-8104 [Abstract] [Full Text]
Planelles, L., Thomas, M. C., Alonso, C., Lopez, M. C. (2001). DNA Immunization with Trypanosoma cruzi HSP70 Fused to the KMP11 Protein Elicits a Cytotoxic and Humoral Immune Response against the Antigen and Leads to Protection. Infect. Immun. 69: 6558-6563 [Abstract] [Full Text]
Tangri, S., Ishioka, G. Y., Huang, X., Sidney, J., Southwood, S., Fikes, J., Sette, A. (2001). Structural Features of Peptide Analogs of Human Histocompatibility Leukocyte Antigen Class I Epitopes that Are More Potent and Immunogenic than Wild-Type Peptide. J. Exp. Med. 194: 833-846 [Abstract] [Full Text]
Tindle, R. W., Herd, K., Doan, T., Bryson, G., Leggatt, G. R., Lambert, P., Frazer, I. H., Street, M. (2001). Nonspecific Down-Regulation of CD8+ T-Cell Responses in Mice Expressing Human Papillomavirus Type 16 E7 Oncoprotein from the Keratin-14 Promoter. J. Virol. 75: 5985-5997 [Abstract] [Full Text]
Butterfield, L. H., Meng, W. S., Koh, A., Vollmer, C. M., Ribas, A., Dissette, V. B., Faull, K., Glaspy, J. A., McBride, W. H., Economou, J. S. (2001). T Cell Responses to HLA-A*0201-Restricted Peptides Derived from Human {{alpha}} Fetoprotein. J. Immunol. 166: 5300-5308 [Abstract] [Full Text]
Miconnet, I., Coste, I., Beermann, F., Haeuw, J.-F., Cerottini, J.-C., Bonnefoy, J.-Y., Romero, P., Renno, T. (2001). Cancer Vaccine Design: A Novel Bacterial Adjuvant for Peptide-Specific CTL Induction. J. Immunol. 166: 4612-4619 [Abstract] [Full Text]
Altfeld, M. A., Livingston, B., Reshamwala, N., Nguyen, P. T., Addo, M. M., Shea, A., Newman, M., Fikes, J., Sidney, J., Wentworth, P., Chesnut, R., Eldridge, R. L., Rosenberg, E. S., Robbins, G. K., Brander, C., Sax, P. E., Boswell, S., Flynn, T., Buchbinder, S., Goulder, P. J. R., Walker, B. D., Sette, A., Kalams, S. A. (2001). Identification of Novel HLA-A2-Restricted Human Immunodeficiency Virus Type 1-Specific Cytotoxic T-Lymphocyte Epitopes Predicted by the HLA-A2 Supertype Peptide-Binding Motif. J. Virol. 75: 1301-1311 [Abstract] [Full Text]
Allen, T. M., Mothé, B. R., Sidney, J., Jing, P., Dzuris, J. L., Liebl, M. E., Vogel, T. U., O'Connor, D. H., Wang, X., Wussow, M. C., Thomson, J. A., Altman, J. D., Watkins, D. I., Sette, A. (2001). CD8+ Lymphocytes from Simian Immunodeficiency Virus-Infected Rhesus Macaques Recognize 14 Different Epitopes Bound by the Major Histocompatibility Complex Class I Molecule Mamu-A*01: Implications for Vaccine Design and Testing. J. Virol. 75: 738-749 [Abstract] [Full Text]
Sutmuller, R. P. M., Schurmans, L. R. H. M., van Duivenvoorde, L. M., Tine, J. A., van der Voort, E. I. H., Toes, R. E. M., Melief, C. J. M., Jager, M. J., Offringa, R. (2000). Adoptive T Cell Immunotherapy of Human Uveal Melanoma Targeting gp100. J. Immunol. 165: 7308-7315 [Abstract] [Full Text]
Geluk, A., van Meijgaarden, K. E., Franken, K. L. M. C., Drijfhout, J. W., D'Souza, S., Necker, A., Huygen, K., Ottenhoff, T. H. M. (2000). Identification of Major Epitopes of Mycobacterium tuberculosis AG85B That Are Recognized by HLA-A*0201-Restricted CD8+ T Cells in HLA-Transgenic Mice and Humans. J. Immunol. 165: 6463-6471 [Abstract] [Full Text]
Borenstein, S. H., Graham, J., Zhang, X.-L., Chamberlain, J. W. (2000). CD8+ T Cells Are Necessary for Recognition of Allelic, But Not Locus-Mismatched or Xeno-, HLA Class I Transplantation Antigens. J. Immunol. 165: 2341-2353 [Abstract] [Full Text]
Pepperl, S., Münster, J., Mach, M., Harris, J. R., Plachter, B. (2000). Dense Bodies of Human Cytomegalovirus Induce both Humoral and Cellular Immune Responses in the Absence of Viral Gene Expression. J. Virol. 74: 6132-6146 [Abstract] [Full Text]
Bullock, T. N. J., Colella, T. A., Engelhard, V. H. (2000). The Density of Peptides Displayed by Dendritic Cells Affects Immune Responses to Human Tyrosinase and gp100 in HLA-A2 Transgenic Mice. J. Immunol. 164: 2354-2361 [Abstract] [Full Text]
Arichi, T., Saito, T., Major, M. E., Belyakov, I. M., Shirai, M., Engelhard, V. H., Feinstone, S. M., Berzofsky, J. A. (2000). Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model. Proc. Natl. Acad. Sci. USA 97: 297-302 [Abstract] [Full Text]
Peh, C. A., Laham, N., Burrows, S. R., Zhu, Y., McCluskey, J. (2000). Distinct Functions of Tapasin Revealed by Polymorphism in MHC Class I Peptide Loading. J. Immunol. 164: 292-299 [Abstract] [Full Text]
Lauvau, G., Kakimi, K., Niedermann, G., Ostankovitch, M., Yotnda, P., Firat, H., Chisari, F. V., van Endert, P. M. (1999). Human Transporters Associated with Antigen Processing (TAPs) Select Epitope Precursor Peptides for Processing in the Endoplasmic Reticulum and Presentation to T Cells. J. Exp. Med. 190: 1227-1240 [Abstract] [Full Text]
Vissers, J. L. M., De Vries, I. J. M., Schreurs, M. W. J., Engelen, L. P. H., Oosterwijk, E., Figdor, C. G., Adema, G. J. (1999). The Renal Cell Carcinoma-associated Antigen G250 Encodes a Human Leukocyte Antigen (HLA)-A2.1-restricted Epitope Recognized by Cytotoxic T Lymphocytes. Cancer Res. 59: 5554-5559 [Abstract] [Full Text]
Drexler, I., Antunes, E., Schmitz, M., Wolfel, T., Huber, C., Erfle, V., Rieber, P., Theobald, M., Sutter, G. (1999). Modified Vaccinia Virus Ankara for Delivery of Human Tyrosinase as Melanoma-associated Antigen: Induction of Tyrosinase- and Melanoma-specific Human Leukocyte Antigen A*0201-restricted Cytotoxic T Cells in Vitro and in Vivo. Cancer Res. 59: 4955-4963 [Abstract] [Full Text]
Ureta-Vidal, A., Firat, H., Perarnau, B., Lemonnier, F. A. (1999). Phenotypical and Functional Characterization of the CD8+ T Cell Repertoire of HLA-A2.1 Transgenic, H-2Kb{degrees}Db{degrees} Double Knockout Mice. J. Immunol. 163: 2555-2560 [Abstract] [Full Text]
Doan, T., Herd, K., Street, M., Bryson, G., Fernando, G., Lambert, P., Tindle, R. (1999). Human Papillomavirus Type 16�E7 Oncoprotein Expressed in Peripheral Epithelium Tolerizes E7-Directed Cytotoxic T-Lymphocyte Precursors Restricted through Human (and Mouse) Major Histocompatibility Complex Class I Alleles. J. Virol. 73: 6166-6170 [Abstract] [Full Text]
Butterfield, L. H., Koh, A., Meng, W., Vollmer, C. M., Ribas, A., Dissette, V., Lee, E., Glaspy, J. A., McBride, W. H., Economou, J. S. (1999). Generation of Human T-cell Responses to an HLA-A2.1-restricted Peptide Epitope Derived from {{alpha}}-Fetoprotein. Cancer Res. 59: 3134-3142 [Abstract] [Full Text]
Irvine, K. R., Parkhurst, M. R., Shulman, E. P., Tupesis, J. P., Custer, M., Touloukian, C. E., Robbins, P. F., Yafal, A. G., Greenhalgh, P., Sutmuller, R. P. M., Offringa, R., Rosenberg, S. A., Restifo, N. P. (1999). Recombinant Virus Vaccination against "Self" Antigens UsingAnchor-fixed Immunogens. Cancer Res. 59: 2536-2540 [Abstract] [Full Text]
Ishioka, G. Y., Fikes, J., Hermanson, G., Livingston, B., Crimi, C., Qin, M., France del Guercio, M., Oseroff, C., Dahlberg, C., Alexander, J., Chesnut, R. W., Sette, A. (1999). Utilization of MHC Class I Transgenic Mice for Development of Minigene DNA Vaccines Encoding Multiple HLA-Restricted CTL Epitopes. J. Immunol. 162: 3915-3925 [Abstract] [Full Text]
Men, Y., Miconnet, I., Valmori, D., Rimoldi, D., Cerottini, J.-C., Romero, P. (1999). Assessment of Immunogenicity of Human Melan-A Peptide Analogues in HLA-A*0201/Kb Transgenic Mice. J. Immunol. 162: 3566-3573 [Abstract] [Full Text]
Khanna, R., Sherritt, M., Burrows, S. R. (1999). EBV Structural Antigens, gp350 and gp85, as Targets for Ex Vivo Virus-Specific CTL During Acute Infectious Mononucleosis: Potential Use of gp350/gp85 CTL Epitopes for Vaccine Design. J. Immunol. 162: 3063-3069 [Abstract] [Full Text]
van der Burg, S. H., Kwappenberg, K. M. C., Geluk, A., van der Kruk, M., Pontesilli, O., Hovenkamp, E., Franken, K. L. M. C., van Meijgaarden, K. E., Drijfhout, J.-W., Ottenhoff, T. H. M., Melief, C. J. M., Offringa, R. (1999). Identification of a Conserved Universal Th Epitope in HIV-1 Reverse Transcriptase That Is Processed and Presented to HIV-Specific CD4+ T Cells by at Least Four Unrelated HLA-DR Molecules. J. Immunol. 162: 152-160 [Abstract] [Full Text]
Shields, M. J., Kubota, R., Hodgson, W., Jacobson, S., Biddison, W. E., Ribaudo, R. K. (1998). The Effect of Human beta 2-Microglobulin on Major Histocompatibility Complex I Peptide Loading and the Engineering of a High Affinity Variant. IMPLICATIONS FOR PEPTIDE-BASED VACCINES. J. Biol. Chem. 273: 28010-28018 [Abstract] [Full Text]
Correale, P., Walmsley, K., Zaremba, S., Zhu, M., Schlom, J., Tsang, K. Y. (1998). Generation of Human Cytolytic T Lymphocyte Lines Directed Against Prostate-Specific Antigen (PSA) Employing a PSA Oligoepitope Peptide. J. Immunol. 161: 3186-3194 [Abstract] [Full Text]
Allen, T. M., Sidney, J., del Guercio, M.-F., Glickman, R. L., Lensmeyer, G. L., Wiebe, D. A., DeMars, R., Pauza, C. D., Johnson, R. P., Sette, A., Watkins, D. I. (1998). Characterization of the Peptide Binding Motif of a Rhesus MHC Class I Molecule (Mamu-A*01) That Binds an Immunodominant CTL Epitope from Simian Immunodeficiency Virus. J. Immunol. 160: 6062-6071 [Abstract] [Full Text]
Smith, P. A., Potter, T. A. (1998). Alloreactive T Cells That Do Not Require TCR and CD8 Coengagement Are Present in Naive Mice and Contribute to Graft Rejection. J. Immunol. 160: 5382-5389 [Abstract] [Full Text]
Valmori, D., Fonteneau, J.-F., Lizana, C. M., Gervois, N., Lienard, D., Rimoldi, D., Jongeneel, V., Jotereau, F., Cerottini, J.-C., Romero, P. (1998). Enhanced Generation of Specific Tumor-Reactive CTL In Vitro by Selected Melan-A/MART-1 Immunodominant Peptide Analogues. J. Immunol. 160: 1750-1758 [Abstract] [Full Text]
Pascolo, S., Bervas, N., Ure, J. M., Smith, A. G., Lemonnier, F. A., Perarnau, B. (1997). HLA-A2.1-restricted Education and Cytolytic Activity of CD8+ T Lymphocytes from beta 2 Microglobulin (beta 2m) HLA-A2.1 Monochain Transgenic H-2Db beta 2m Double Knockout Mice. J. Exp. Med. 185: 2043-2051 [Abstract] [Full Text]
Wei, C., Willis, R. A., Tilton, B. R., Looney, R. J., Lord, E. M., Barth, R. K., Frelinger, J. G. (1997). Tissue-specific expression of the human prostate-specific antigen gene in transgenic mice: Implications for tolerance and�immunotherapy. Proc. Natl. Acad. Sci. USA 94: 6369-6374 [Abstract] [Full Text]
Theobald, M., Biggs, J., Hernandez, J., Lustgarten, J., Labadie, C., Sherman, L. A. (1997). Tolerance to p53 by A2.1-restricted Cytotoxic T Lymphocytes. J. Exp. Med. 185: 833-842 [Abstract] [Full Text]
Sherman, L., Hesse, S., Irwin, M., La Face, D, Peterson, P (1992). Selecting T cell receptors with high affinity for self-MHC by decreasing the contribution of CD8. Science 258: 815-818 [Abstract]
Miconnet, I., Servis, C., Cerottini, J.-C., Romero, P., Levy, F. (2000). Amino Acid Identity and/or Position Determines the Proteasomal Cleavage of the HLA-A*0201-restricted Peptide Tumor Antigen MAGE-3271-279. J. Biol. Chem. 275: 26892-26897 [Abstract] [Full Text]
Minev, B., Hipp, J., Firat, H., Schmidt, J. D., Langlade-Demoyen, P., Zanetti, M. (2000). Cytotoxic T cell immunity against telomerase reverse transcriptase in humans. Proc. Natl. Acad. Sci. USA 97: 4796-4801 [Abstract] [Full Text]